2022-RA-1354-ESGO A new algorithm may highlight benefits from adding HE4 to CA125 in the preoperative assessment of premenopausal patients with pelvic mass

Abstract

Introduction/BackgroundRecently, ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors implied that neither Human epididymis protein 4 (HE4) nor Risk of Ovarian Malignancy Algorithm (ROMA) improve the discrimination between benign...